Kern Capital, LLC — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
4J TherapeuticsAug 2022
BiotechPalo Alto, US
Edward Pham(Executive Officer, Director)Jeffrey S. Glenn(Director)Menashe Elazar(Executive Officer, Director)Nancy Chang(Executive Officer)
PartnerJay Kern· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.